Epidemiology & Genomics Research Program

Supporting research in human populations to understand determinants of cancer occurrence and outcomes and translating findings to clinical and public health interventions.

Funding Opportunities

Assay Validation of High Quality Markers for Clinical Studies in Cancer

PAR-20-313 (UH2/UH3, Clinical Trial Not Allowed) and PAR-20-314 (UH3, Clinical Trials Not Allowed)
Expires October 11, 2023

Co-infection and Cancer

PAR-20-061 (R21 Clinical Trial Not Allowed) and PAR-20-062 (R01 Clinical Trial Not Allowed)
Expires January 8, 2023

Core Infrastructure Support for Cancer Epidemiology Cohorts

PAR-20-294 (U01 - Clinical Trial Not Allowed)
Expires November 10, 2022

Notice of Special Interest: Research in the Emergency Setting

NOT-NS-20-005
Expires September 8, 2022

Genomic Expert Curation Panels

PAR-20-101 (U24 - Clinical Trial Not Allowed)
Expires May 27, 2022

Diet and Physical Activity Assessment Methodology

PA-18-856 (R01 - Clinical Trial Not Allowed) and PAR-18-857 (R21 - Clinical Trial Not Allowed)
Expires September 8, 2021

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors

RFA-CA-20-027 (R01 - Clinical Trial Optional) and RFA-CA-20-028 (R21 - Clinical Trial Optional)
Expires July 31, 2021

Utilizing In Vitro Functional Genomics Advances for Gene-Environment (GxE) Discovery and Validation

RFA-ES-20-018 (R01, Clinical Trial Not Allowed)
Expires February 2, 2021

New Cohorts for Environmental Exposures and Cancer Risk & Coordinating Center

RFA-CA-20-049 (UG3/UH3 - Clinical Trial Not Allowed) and RFA-CA-20-050 (U24 - Clinical Trial Not Allowed)
Expires January 30, 2021

Find More Opportunities

Featured Event

National Cancer Institute Cannabis, Cannabinoids, and Cancer Research Symposium

This virtual meeting will be held December 15-18, 2020. To learn more and register, click the link below:

Register for the Symposium

Meet Our Associate Director

An Interview with Kathy J. Helzlsouer, M.D., M.H.S.

Dr. Helzlsouer speaks about her background in oncology and epidemiology, the people and experiences that drive her passion for cancer research, and her ideas about future directions for EGRP.

Watch the InterviewExternal Web Site Policy

What's New

Body Composition and Cancer Outcomes Research Webinar Series

The purpose of this new webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research on integrating measures of body composition in cancer epidemiology research.

Survivorship Activities of the National Cancer Institute

In order to address the unique needs of the growing cancer survivor population, NCI and the Division of Cancer Control and Population Sciences (DCCPS), remains focused on supporting cancer survivorship research through more than 20 funding opportunity announcements and more than 100 active grants. Read more about the NCI- and DCCPS-sponsored activities that promote cancer survivorship research.

New Videos in the Video Library

Check out the new additions to our video library, which features 20+ archived cancer epidemiology webinars and presentations.

Information on Notices of Special Interest (NOSIs) and How They Work

A NOSI describes aims in a specific scientific area and points to one or more funding opportunity announcements that investigators can apply to for support. Visit our overview of NOSIs for additional details.

Considerations when Developing a Data Sharing Plan

Tips for investigators on preparing data sharing plans that comply with NIH's data sharing policies.

Connect With Us

Subscribe for Updates

Subscribe
You can subscribe and unsubscribe at any time by entering your email address and selecting your preferences on the page that follows.

Subscribe to the E-Newsletter

Follow Us on Twitter

Need Help?

EGRP staff can answer questions on grant funding, policies, and research resources. If you do not know who to contact we will do our best to connect you with someone who can help you.

Email Us
(240) 276-6730
Last Updated: 15 Dec, 2020